Burns : journal of the International Society for Burn Injuries
Glucagon-like peptide-1 receptor agonists after recent burn injury are associated with lower rates of infection, mortality, and opioid prescriptions.
Matthew Q Dao, Anika Y Kim, Sarah Wang, Paul Won, Matteo Laspro, T Justin Gillenwater, Haig A Yenikomshian, Maxwell B Johnson
Published: 202510.1016/j.burns.2025.107848
Abstract
INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely prescribed for glycemic control and weight loss. In addition, these medications have been associated with anti-inflammatory activity, modulation of wound healing, and redu…
Preview only. Read the full abstract at the source